Page last updated: 2024-09-05

aminopterin and Mycosis Fungoides

aminopterin has been researched along with Mycosis Fungoides in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	6 (75.00)	24.3611
2020's	2 (25.00)	2.80

Authors

Authors	Studies
Fujioka, A; Kobashi, H; Kusume, E; Nakajima, H; Oguro, T; Sano, H; Sano, S; Teraishi, M; Yamamoto, M	1
Cannell, P; Creeper, KJ; Frederiks, AJ; Radeski, D; Spagnolo, DV	1
Desai, N; Goff, HW; Rizvi, S; Stewart, JR; Zhu, H	1
Geskin, LJ; Koch, E; Story, SK	1
Duvic, M; Gangar, P; Talpur, R; Thompson, A	1
Duvic, M	1
Bartlett, N; Coiffier, B; Foss, F; Furman, RR; Haioun, C; Horwitz, SM; Koutsoukos, T; O'Connor, OA; Pinter-Brown, LC; Popplewell, L; Pro, B; Shustov, A	1
Schmidt, C	1

Reviews

1 review(s) available for aminopterin and Mycosis Fungoides

Article	Year
Alemtuzumab is an effective third-line treatment versus single-agent gemcitabine or pralatrexate for refractory Sézary syndrome: a systematic review. European journal of dermatology : EJD, 2018, Dec-01, Volume: 28, Issue:6 Topics: Alemtuzumab; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Deoxycytidine; Folic Acid Antagonists; Gemcitabine; Humans; Mycosis Fungoides; Retreatment; Sezary Syndrome; Skin Neoplasms	2018

Article

Year

Alemtuzumab is an effective third-line treatment versus single-agent gemcitabine or pralatrexate for refractory Sézary syndrome: a systematic review.

European journal of dermatology : EJD, 2018, Dec-01, Volume: 28, Issue:6

Topics: Alemtuzumab; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Deoxycytidine; Folic Acid Antagonists; Gemcitabine; Humans; Mycosis Fungoides; Retreatment; Sezary Syndrome; Skin Neoplasms

2018

Trials

1 trial(s) available for aminopterin and Mycosis Fungoides

Article	Year
Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study. Clinical lymphoma, myeloma & leukemia, 2012, Volume: 12, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Folic Acid Antagonists; Humans; Middle Aged; Mycosis Fungoides; Prognosis; Recurrence; Retrospective Studies; Survival Analysis	2012

Article

Year

Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study.

Clinical lymphoma, myeloma & leukemia, 2012, Volume: 12, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Folic Acid Antagonists; Humans; Middle Aged; Mycosis Fungoides; Prognosis; Recurrence; Retrospective Studies; Survival Analysis

2012

Other Studies

6 other study(ies) available for aminopterin and Mycosis Fungoides

Article	Year
Pralatrexate for refractory mycosis fungoides in two Japanese patients. The Journal of dermatology, 2021, Volume: 48, Issue:5 Topics: Aminopterin; Humans; Japan; Mycosis Fungoides; Neoplasm Recurrence, Local; Skin Neoplasms	2021
Complete remission of stage IV erythrodermic mycosis fungoides with large cell transformation through combination of pralatrexate and romidepsin followed by allogeneic hematopoietic stem cell transplantation. The Australasian journal of dermatology, 2021, Volume: 62, Issue:3 Topics: Aminopterin; Antibiotics, Antineoplastic; Depsipeptides; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Mycosis Fungoides; Remission Induction; Skin Neoplasms; Treatment Outcome	2021
Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacy. Leukemia & lymphoma, 2013, Volume: 54, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Female; Folic Acid Antagonists; Humans; Leucovorin; Lymph Nodes; Lymphoma, T-Cell, Peripheral; Male; Mycosis Fungoides; Premedication; Skin; Tomography, X-Ray Computed	2013
Pralatrexate alone or in combination with bexarotene: long-term tolerability in relapsed/refractory mycosis fungoides. Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; Retrospective Studies; Tetrahydronaphthalenes; Treatment Outcome	2014
Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome. Hematology. American Society of Hematology. Education Program, 2015, Volume: 2015 Topics: Alemtuzumab; Aminopterin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Clinical Trials as Topic; Deoxycytidine; Depsipeptides; Diphtheria Toxin; Disease Progression; Doxorubicin; Electrons; Gemcitabine; Humans; Hydroxamic Acids; Immunotherapy; Incidence; Interleukin-2; Lenalidomide; Lymphoma, T-Cell; Mycosis Fungoides; Pentostatin; Photopheresis; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Retinoids; Sezary Syndrome; Stem Cell Transplantation; Thalidomide; United States; Vorinostat	2015
Cutaneous T-cell lymphoma's confounding nature. Journal of the National Cancer Institute, 2012, Jun-06, Volume: 104, Issue:11 Topics: Aged; Alemtuzumab; Aminopterin; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Brentuximab Vedotin; Delayed Diagnosis; Diagnosis, Differential; Humans; Immunoconjugates; Lymphoma, T-Cell, Cutaneous; Male; Mycosis Fungoides; Remission Induction; Sezary Syndrome; Stem Cell Transplantation; Tetrahydronaphthalenes; Transplantation, Homologous	2012